JAMA & Archives
SEARCH
GO TO ADVANCED SEARCH
-
HOME  SUBSCRIPTIONS  E-MAIL ALERTS  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP

Adverse Effects

Contributing journals to this collection:
JAMA & Archives Journals

Citations 311-320 of 1622 total displayed.

Past content

JAMA
Letters
Sildenafil as Treatment for Antidepressant-Induced Sexual Dysfunction
Liu Hong; Kaichun Wu; Daiming Fan
JAMA 2008; 300: 2365-a. [Extract] [Full text] [PDF]  

JAMA
Letters
Sildenafil as Treatment for Antidepressant-Induced Sexual Dysfunction
Lisa Harinstein
JAMA 2008; 300: 2365. [Extract] [Full text] [PDF]  

JAMA
Commentaries
Benefits and Risks of Drug Treatments: How to Combine the Best Evidence on Benefits With the Best Data About Adverse Effects
Jan P. Vandenbroucke; Bruce M. Psaty
JAMA 2008; 300: 2417-2419. [Extract] [Full text] [PDF]  

Arch Intern Med
Original Investigations
Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy
Wolfgang C. Winkelmayer; Soko Setoguchi; Raisa Levin; Daniel H. Solomon
Arch Intern Med 2008; 168: 2368-2375. [Abstract] [Full text] [PDF]  

Arch Intern Med
Editor's Correspondence
Alendronate, Osteoporosis, and Atherosclerosis
Timo E. Strandberg
Arch Intern Med 2008; 168: 2386-b-2387-b. [Extract] [Full text] [PDF]  

Arch Intern Med
Editor's Correspondence
Limitations of the Anticholinergic Risk Scale—Reply
James L. Rudolph; Marci J. Salow; Michael C. Angelini; Regina E. McGlinchey
Arch Intern Med 2008; 168: 2386-a. [Extract] [Full text] [PDF]  

Arch Intern Med
Editor's Correspondence
Limitations of the Anticholinergic Risk Scale
Madan Kwatra
Arch Intern Med 2008; 168: 2386. [Extract] [Full text] [PDF]  

Arch Intern Med
Editor's Correspondence
Alendronate, Osteoporosis, and Atherosclerosis—Reply
Susan R. Heckbert; Guo Li; Steven R. Cummings; Nicholas L. Smith; Bruce M. Psaty
Arch Intern Med 2008; 168: 2387. [Extract] [Full text] [PDF]  

JAMA
Corrections
Incorrect Table Column Headings and Inaccurate Information in Text in: Effects of a Reduced Dose Schedule and Intramuscular Administration of Anthrax Vaccine Adsorbed on Immunogenicity and Safety at 7 Months
JAMA 2008; 300: 2252. [Full text] [PDF]  

JAMA
Reviews
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients: A Meta-analysis
Shobha Rani Nalluri; David Chu; Roger Keresztes; Xiaolei Zhu; Shenhong Wu
JAMA 2008; 300: 2277-2285. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163

 Collections
 •Topic Collections Home
 •Related collections:
  •Drug Therapy
  •Adherence
  •Adverse Effects
  •Medication Error
  •Pediatric Dosing
  •Drug Therapy, Other
Advertisement




HOME | SUBSCRIPTIONS | E-MAIL ALERTS | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.